Insys Plans $29M CBD And Naloxone Sale In Ch. 11

By Chris Villani · August 9, 2019, 3:13 PM EDT

Embattled and bankrupt drugmaker Insys Therapeutics Inc. has entered into agreements to sell the company's naloxone spray and cannabis-based products to a pair of companies for a total of $29 million,...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Insys Therapeutics, Inc.

Case Number

1:19-bk-11292

Court

Delaware

Nature of Suit

Date Filed

June 10, 2019